Safety of dipyrone (metamizole) in children-What's the risk of agranulocytosis?

Paediatr Anaesth. 2018 Feb;28(2):186-187. doi: 10.1111/pan.13312.

Authors

Victoria C Ziesenitz¹, Thomas O Erb², Daniel Trachsel³, Johannes N van den Anker¹

Affiliations

¹ Division of Paediatric Pharmacology and Pharmacometrics, University of Basel Children's Hospital, Basel, Switzerland.
² Division of Paediatric Anaesthesiology, University of Basel Children's Hospital, Basel, Switzerland.
³ Division of Paediatric Pulmonology and Intensive Care, University of Basel Children's Hospital, Basel, Switzerland.

PMID: 29345086
DOI: 10.1111/pan.13312

No abstract available

Publication types

Letter
Comment

MeSH terms

Agranulocytosis*
Anti-Inflammatory Agents, Non-Steroidal
Child
Dipyrone*
Humans
Risk

Substances

Anti-Inflammatory Agents, Non-Steroidal
Dipyrone